Renal Stone clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18 years and up
This is a randomized, triple-masked, placebo-controlled parallel-arm human subjects clinical trial investigating the addition of a continuous erector spinae plane nerve block to a single-injection erector spinae plane block to provide postoperative analgesia following percutaneous nephrolithotomy. Participants will all receive a single-injection nerve block and perineural catheter insertion. Following surgery, participants will be randomly allocated to receive either perineural local anesthetic or normal saline until the second day following surgery.
Our lead scientists for Renal Stone research studies include Brian M Ilfeld, MD, MS.